mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0004 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0007 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |